–International expansion drove a strong beat for 3Q results
–2Q23 beat on record-high margin; Reiterate BUY
–3Q23 earnings beat on better product mix and record-high GPM
Growth beat expectations with recovery underway
–A decent 1H, though not a straight beat
Earnings beat with double surprises on dividend payout; Maintain Buy
3Q24 net profit +38% YoY, beat expectations; US remains the most promising market
1H23 NBV beat consensus; interim dividend up 1.1% YoY reinforcing a long-run growth story
1Q23 results beat and expect gradual recovery
–GPM pressure persists despite possible sales beat